LTC pharmacists make case to remove barriers for more home-and community-based services
By Adam Healy
McKnight’s Long Term Care News
Federal regulators and policy makers have increasingly coaxed long-term care patients and services to migrate more to home- and community-based settings in recent years.
Now it’s time to allow long-term care pharmacists to do the same, without barriers that have been imposed by lawmakers for years, according to new study findings from the Senior Care Pharmacy Coalition (SCPC) and healthcare analysis firm ATI Advisory.
Their report, “The role of long term care pharmacy in supporting individuals with long-term services and supports needs,” was officially released Tuesday (July 25).
“LTC pharmacy is rarely provided at home due to longstanding policy and operational barriers,” despite the recent overall shift away from institutional care settings, report authors said.
Read the full original article here.
Recent Posts
-
SCPC Congratulates RFK Jr. on Being Confirmed as Secretary of Health and Human Services
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released the following statement today to congratulate Robert F. Kennedy Jr. for being confirmed as Secretary of the U.S. Department of Health and Human Services (HHS).
-
SCPC Calls for Immediate Congressional Action to Fix Broken LTC Pharmacy Payment Model as More Drugs Become Subject to Mandatory Medicare Price Negotiations
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
SCPC Praises FTC for Report Highlighting Egregious PBM Abuses; Encourages Congress and New Administration to Make PBM Reform an Immediate Priority in 2025
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.